Quarterly report [Sections 13 or 15(d)]

DERIVATIVE FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS (Tables)

v3.25.4
DERIVATIVE FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS (Tables)
6 Months Ended
Dec. 31, 2025
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
SCHEDULE OF FAIR VALUE MEASUREMENTS OF CONVERTIBLE DEBT VALUATION TECHNIQUES

 

   

Initial Valuations
(on new derivative
instruments entered

into during the three
months ended
December 31, 2025)

    December 31, 2025  
Volatility     -       413 %
Expected Remaining Term (in years)     -       0.002  
Risk Free Interest Rate     -       4.40 %
Expected dividend yield     None       None  
SCHEDULE OF FAIR VALUE OF ASSETS AND LIABILITIES MEASURED ON RECURRING BASIS

 

    Balance at
December 31, 2025
   

Quoted Prices

in Active

Markets for

Identical
Assets

   

Significant

Other

Observable
Inputs

   

Significant

Unobservable Inputs

 
          (Level 1)     (Level 2)     (Level 3)  
Warrant liability   $ 288,635     $     $     $ 288,635  
Embedded conversion option liabilities     32,128                   32,128  
Total   $ 320,763     $     $     $ 320,763  

 

 

PROPANC BIOPHARMA, INC. AND SUBSIDIARY
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
December 31, 2025
(Unaudited)

 

    Balance at
June 30, 2025
   

Quoted Prices

in Active

Markets for

Identical
Assets

   

Significant

Other

Observable
Inputs

   

Significant

Unobservable Inputs

 
          (Level 1)     (Level 2)     (Level 3)  
Embedded conversion option liabilities   $ 403,892     $     $     $ 403,892  
Total   $ 403,892     $     $     $ 403,892  
SCHEDULE OF FAIR VALUE LIABILITY OF PRICE ADJUSTABLE DERIVATIVE INSTRUMENTS

The following is a roll forward for the six months ended December 31, 2025 of the fair value liability of price adjustable derivative instruments:

 

 

    Fair Value of  
    Liability for  
    Derivative  
    Instruments  
Balance at June 30, 2025   $ 403,892  
Gain on debt extinguishment     (303,742 )
Change in fair value included in statements of operations     (68,022 )
Balance at December 31, 2025   $ 32,128  
SUMMARY OF THE CHANGES IN THE FAIR VALUE OF THE LEVEL 3 WARRANT LIABILITY

The following table sets forth a summary of the changes in the fair value of the Level 3 warrant liability for the six months ended December 31, 2025:

    Warrant
Liability
 
Fair value as of June 30, 2025   $ -  
Initial fair value of warrant liability upon issuance     882,345  
Change in fair value of warrant liability     (593,710 )
Fair value as of December 31, 2025   $ 288,635